NCT03696095View on ClinicalTrials.gov

Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

December 6, 2018

Conditions

Postoperative PainPostoperative Complications

Interventions

DRUG

Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)

programmed intermittent bolus 5ml each one hour.

DRUG

Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)

continuous infusion 6ml/h

Trial Locations (1)

4000

CHU Liege, Liège

All Listed Sponsors

lead

J P Lecoq

OTHER

NCT03696095 - Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block. | Biotech Hunter | Biotech Hunter